Chengyan Zhang

Zhejiang Provincial Key Laboratory Of Pancreatic Disease
Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A novel extracellular vesicle-engineered immunotherapy drug for Her2+ breast cancer.

A novel extracellular vesicle-engineered immunotherapy drug for Her2+ breast cancer.

Journal: Journal of advanced research

Published: August 25, 2025

CD7-targeting pro-apoptotic extracellular vesicles: A novel approach for T-cell haematological malignancy therapy.

CD7-targeting pro-apoptotic extracellular vesicles: A novel approach for T-cell haematological malignancy therapy.

Journal: Journal of extracellular vesicles

Published: April 03, 2024

Proton pump inhibitors enhance macropinocytosis-mediated extracellular vesicle endocytosis by inducing membrane v-ATPase assembly.

Proton pump inhibitors enhance macropinocytosis-mediated extracellular vesicle endocytosis by inducing membrane v-ATPase assembly.

Journal: Journal of extracellular vesicles

Published: October 12, 2023

Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses.

Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses.

Journal: Theranostics

Published: August 14, 2023

Comprehensive analysis to identify the influences of SARS-CoV-2 infections to inflammatory bowel disease.

Comprehensive analysis to identify the influences of SARS-CoV-2 infections to inflammatory bowel disease.

Journal: Frontiers in immunology

Published: August 22, 2022

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1.

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1.

Journal: Cellular & molecular immunology

Published: June 09, 2022

Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation.

Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation.

Journal: Nature communications

Published: August 25, 2021

Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer.

Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer.

Journal: Frontiers in immunology

Published: September 05, 2020

Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China.

Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China.

Journal: Journal of immunology research

Published: August 22, 2019

Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011-2015.

Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011-2015.

Journal: Journal of thoracic disease

Published: August 26, 2017

Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis.

Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis.

Journal: Oncotarget

Published: June 16, 2017

Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.

Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.

Journal: Cellular & molecular immunology

Published: February 20, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026